IHM
GBT

Iguana Healthcare Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Iguana Healthcare Management’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-100,000
Closed -$5.25M – 83
2016
Q3 		$5.25M Buy
+100,000
New +$1.91M 0.94% 38

Other funds holding GBT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Iguana Healthcare Management's GBT Position: Q1 2018 in Review

Iguana Healthcare Management reduced its Global Blood Therapeutics, Inc. (GBT) stake by 8% in Q1 2018, selling an estimated $558K and leaving 115,000 shares worth $5.55M. The position accounts for 3.65% of the portfolio, ranked #4.

Iguana Healthcare Management first reported a position in GBT in Q3 2015 and has held it in 11 quarters since. The position peaked at $15M in Q3 2016. 176 funds tracked by Wall St. Rank hold GBT as of Q1 2018.

  • Iguana Healthcare Management held 115,000 shares of Global Blood Therapeutics, Inc. worth $5.55M as of Q1 2018.
  • Iguana Healthcare Management sold 10,000 Global Blood Therapeutics, Inc. shares in Q1 2018, an estimated $558K.
  • Global Blood Therapeutics, Inc. made up 3.65% of Iguana Healthcare Management's portfolio in Q1 2018, its #4 holding.
  • Iguana Healthcare Management first reported a position in Global Blood Therapeutics, Inc. in Q3 2015 and has held it in 11 quarters since.
  • Iguana Healthcare Management's Global Blood Therapeutics, Inc. position peaked at $15M in Q3 2016.
  • 176 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q1 2018.

Based on Iguana Healthcare Management's 13F filing for Q1 2018, filed 15 May 2018.